Healthcare Exhibition 2026: How Artificial Intelligence is Changing Patient Treatment Approaches in South Africa
Read more
Food For Mzansi
foodformzansi.co.za

Healthcare Exhibition 2026: How Artificial Intelligence is Changing Patient Treatment Approaches in South Africa

South Africa's healthcare sector is actively transitioning to data-driven diagnostics and Artificial Intelligence (AI) for earlier disease detection and reducing the burden on overloaded medical facilities. The World Healthcare Exhibition 2026 will take place in Johannesburg in October, where leaders will gather to discuss responsible AI implementation and patient safety.

The South African healthcare system is transforming into a more predictive, data-based model, utilizing AI-powered diagnostic tools, interoperable electronic health records, and connected medical devices. However, the shift from reactive treatment to timely intervention depends not only on technology; it requires digital solutions that can demonstrate clinical value, safely integrate into care delivery processes, and comply with regulatory requirements.

AI-assisted diagnostic tools are attracting attention due to their potential to accelerate disease discovery, improve workflow efficiency, and expand capabilities in fields such as radiology, pathology, and laboratory medicine. Nevertheless, a successful pilot project alone does not guarantee a product's readiness for routine clinical application.

Medical organizations must evaluate system performance in real-world settings, among representative patient groups, and in conjunction with existing equipment and within the workflows of clinicians responsible for patient care.

This is particularly critical for diagnostic applications. While algorithmic accuracy is important, it does not cover all clinical aspects. Healthcare systems must also analyze the frequency of false positive and false negative results, the stability of metrics across different patient groups and institutions, the ability of doctors to identify or challenge erroneous results, and the implications of algorithm updates or exposure to unfamiliar data.

The commercial opportunity is becoming increasingly tangible. According to Grand View Research’s Horizon Databook, the South African connected healthcare ecosystem, valued at $47 million in 2025, is projected to grow to $77.4 million by 2033. This trend indicates that connected care is moving from an early innovation stage to an established commercial market.

This also raises more pressing issues regarding compliance. The South African Health Products Regulatory Authority (SAHPRA) has confirmed that medical devices with AI and machine learning functions, including autonomous software and software integrated into hardware, fall under the scope of South African medical device regulation. Suppliers must determine the correct regulatory pathway and obtain necessary approval before bringing relevant devices to market or using them in South Africa.

Due diligence for healthcare systems procurement must go beyond vendor technical claims. Decision-makers require clarity on the intended use of the technology, risk classification, clinical evidence, local relevance, known limitations, data governance safeguards, cybersecurity measures, and post-implementation performance monitoring plans.

These issues will be central at the World Healthcare Exhibition (WHX) 2026 in Johannesburg—formerly known as Africa Health—which will take place at the Gallagher Convention Centre from October 6 to 8. Returning to Johannesburg after two events in Cape Town, WHX brings together healthcare providers, laboratory and diagnostic specialists, technology partners, policymakers, investors, distributors, and regulatory stakeholders from South Africa, the Southern African Development Community (SADC), and international markets.

In addition to the exhibition, WHX will host three specialized Indabas focusing on operational, clinical, and commercial aspects shaping the future of African healthcare. The Healthcare Excellence Indaba, on October 6, will provide a platform for senior healthcare executives and decision-makers to explore strategies for building resilient and future-ready healthcare systems. The program will cover hospital infrastructure modernization, global health priorities, ethical decision-making, and how digital transformation, including the responsible adoption of data-driven technologies, can support the development of smarter hospitals.

Professor Edward Kunonga, Chair of the Healthcare Excellence Indaba and Strategic Advisor to Global Health, Durham, UK, stated:

Similar stories

Report indicates that remote monitoring and optimization of intensive care unit operations will be the next areas for AI growth in Indian healthcare
Read more
yourstory.com

Report indicates that remote monitoring and optimization of intensive care unit operations will be the next areas for AI growth in Indian healthcare

According to the report, the next significant potential for artificial intelligence (AI) application in India's healthcare system is focused on remote patient monitoring, optimizing the operation of operating rooms and intensive care units, as well as managing chronic diseases post-discharge.

A joint report by Bain & Company and HealthQuad, titled 'AI in Indian Healthcare Delivery,' demonstrates that healthcare providers in India are transitioning AI from experimental testing to practical application in real-world settings.

The study found that medical institutions are implementing AI to reduce administrative burden on doctors, with connected clinical care being a significant promising opportunity, currently limited by the adoption rate of electronic health records (EHRs) at 35%.

Dhruv Suhrani, Head of Healthcare and Life Sciences Practice in India at Bain & Company, noted that 'the next phase of adoption will be determined by the ability of providers to combine value, deployment capability, and trust—not just access to more advanced AI models.'

The report also highlighted that India's healthcare infrastructure is well-prepared for faster scaling of AI compared to previous digital waves. This is attributed to government initiatives, the growing penetration of EHRs, and a thriving startup ecosystem.

Furthermore, it was noted that since 2023, the volume of expert tasks that AI can perform autonomously has doubled every 6–9 months, while the cost of advanced models has decreased by approximately 92% over the same period.

The report emphasized that as hospitals build the necessary database, the gap between early adopters and the rest of the industry will widen rapidly. Additionally, there remain substantial 'gaps' in areas such as intensive care unit optimization and chronic disease management, where AI can provide significant growth potential.

For startups, providers lacking strong internal technological capabilities represent a major opportunity for integrated platforms. Namit Chug, Director at HealthQuad, stated that 'AI could potentially change this equation, becoming not just an efficiency lever, but a multiplier of capabilities.'

Bain & Company is a global consulting firm that partners with leaders to solve complex challenges and achieve sustainable results across various industries. HealthQuad is a leading healthcare investment platform with assets under management exceeding $500 million, specializing in new models and technologies in healthcare.

Popular